These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 19505772

  • 1. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
    Bisson MA, Beckett KS, McGrouther DA, Grobbelaar AO, Mudera V.
    J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
    [Abstract] [Full Text] [Related]

  • 2. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA, Wang X, Payne WG, Ko F, Robson MC.
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [Abstract] [Full Text] [Related]

  • 3. The contractile properties and responses to tensional loading of Dupuytren's disease--derived fibroblasts are altered: a cause of the contracture?
    Bisson MA, Mudera V, McGrouther DA, Grobbelaar AO.
    Plast Reconstr Surg; 2004 Feb; 113(2):611-21; discussion 622-4. PubMed ID: 14758224
    [Abstract] [Full Text] [Related]

  • 4. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
    Wong M, Mudera V.
    J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinase inhibition reduces contraction by dupuytren fibroblasts.
    Townley WA, Cambrey AD, Khaw PT, Grobbelaar AO.
    J Hand Surg Am; 2008 Nov; 33(9):1608-16. PubMed ID: 18984345
    [Abstract] [Full Text] [Related]

  • 6. Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2.
    Tse R, Howard J, Wu Y, Gan BS.
    BMC Musculoskelet Disord; 2004 Nov 12; 5(1):41. PubMed ID: 15541177
    [Abstract] [Full Text] [Related]

  • 7. An insight into Dupuytren's contracture.
    Murrell GA.
    Ann R Coll Surg Engl; 1992 May 12; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [Abstract] [Full Text] [Related]

  • 8. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J, Rayan GM.
    J Hand Surg Am; 1995 May 12; 20(3):450-5. PubMed ID: 7642925
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
    Rayan GM, Parizi M, Tomasek JJ.
    J Hand Surg Am; 1996 Nov 12; 21(6):1065-70. PubMed ID: 8969433
    [Abstract] [Full Text] [Related]

  • 10. Enhanced fibroblast contraction of 3D collagen lattices and integrin expression by TGF-beta1 and -beta3: mechanoregulatory growth factors?
    Brown RA, Sethi KK, Gwanmesia I, Raemdonck D, Eastwood M, Mudera V.
    Exp Cell Res; 2002 Apr 01; 274(2):310-22. PubMed ID: 11900491
    [Abstract] [Full Text] [Related]

  • 11. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS, Liu C, Chang EY, Carlson CS, Di Cesare PE.
    J Hand Surg Am; 2004 Sep 01; 29(5):809-14. PubMed ID: 15465229
    [Abstract] [Full Text] [Related]

  • 12. Tensional homeostasis in dermal fibroblasts: mechanical responses to mechanical loading in three-dimensional substrates.
    Brown RA, Prajapati R, McGrouther DA, Yannas IV, Eastwood M.
    J Cell Physiol; 1998 Jun 01; 175(3):323-32. PubMed ID: 9572477
    [Abstract] [Full Text] [Related]

  • 13. The role of the fibroblast in Dupuytren's contracture.
    Murrell GA.
    Hand Clin; 1991 Nov 01; 7(4):669-80; discussion 681. PubMed ID: 1769989
    [Abstract] [Full Text] [Related]

  • 14. Cellular structure and biology of Dupuytren's disease.
    Tomasek JJ, Vaughan MB, Haaksma CJ.
    Hand Clin; 1999 Feb 01; 15(1):21-34. PubMed ID: 10050239
    [Abstract] [Full Text] [Related]

  • 15. The mechanical environment in Dupuytren's contracture determines cell contractility and associated MMP-mediated matrix remodeling.
    Verhoekx JS, Beckett KS, Bisson MA, McGrouther DA, Grobbelaar AO, Mudera V.
    J Orthop Res; 2013 Feb 01; 31(2):328-34. PubMed ID: 22987740
    [Abstract] [Full Text] [Related]

  • 16. The role of an MMP inhibitor in the regulation of mechanical tension by Dupuytren's disease fibroblasts.
    Townley WA, Cambrey AD, Khaw PT, Grobbelaar AO.
    J Hand Surg Eur Vol; 2009 Dec 01; 34(6):783-7. PubMed ID: 19786408
    [Abstract] [Full Text] [Related]

  • 17. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
    Kuhn MA, Payne WG, Kierney PC, Pu LL, Smith PD, Siegler K, Ko F, Wang X, Robson MC.
    Int J Surg Investig; 2001 Dec 01; 2(6):443-56. PubMed ID: 12678125
    [Abstract] [Full Text] [Related]

  • 18. Mechanical and migratory properties of normal, scar, and Dupuytren's fibroblasts.
    Viji Babu PK, Rianna C, Belge G, Mirastschijski U, Radmacher M.
    J Mol Recognit; 2018 Sep 01; 31(9):e2719. PubMed ID: 29701269
    [Abstract] [Full Text] [Related]

  • 19. The myofibroblast in Dupuytren's contracture.
    Rudolph R, Vande Berg J.
    Hand Clin; 1991 Nov 01; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
    [Abstract] [Full Text] [Related]

  • 20. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C, Liu F, Gallo PH, Baratz ME, Kathju S, Satish L.
    BMC Musculoskelet Disord; 2016 Nov 11; 17(1):469. PubMed ID: 27835939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.